Cargando…
NS3 genomic sequencing and phylogenetic analysis as alternative to a commercially available assay to reliably determine hepatitis C virus subtypes 1a and 1b
OBJECTIVE: To evaluate the use of hepatitis C virus (HCV) NS3 sequencing as alternative to the comercially available Versant HCV 2.0 reverse hybridization line-probe assay (LiPA 2.0) to determine HCV genotype 1 (HCV-1) subtypes. PATIENTS AND METHODS: A cohort of 104 patients infected by HCV-1 accord...
Autores principales: | Neukam, Karin, Martínez, Alfredo P., Culasso, Andrés C. A., Ridruejo, Ezequiel, García, Gabriel, Di Lello, Federico A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533332/ https://www.ncbi.nlm.nih.gov/pubmed/28753662 http://dx.doi.org/10.1371/journal.pone.0182193 |
Ejemplares similares
-
Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis
por: Guzman, Maria G., et al.
Publicado: (2010) -
Comparison of Three Commercially Available Dengue NS1 Antigen Capture Assays for Acute Diagnosis of Dengue in Brazil
por: Lima, Monique da Rocha Queiroz, et al.
Publicado: (2010) -
Hepatitis C Virus Diversification in Argentina: Comparative Analysis between the Large City of Buenos Aires and the Small Rural Town of O'Brien
por: Golemba, Marcelo D., et al.
Publicado: (2013) -
Commercially available alternatives to palm oil
por: Hinrichsen, Nils
Publicado: (2016) -
Hepatitis C virus treatment failure: Clinical utility for testing resistance-associated substitutions
por: Ridruejo, Ezequiel, et al.
Publicado: (2021)